Zentalis Pharmaceuticals (ZNTL) Other Operating Expenses (2023 - 2025)
Zentalis Pharmaceuticals' (ZNTL) quarterly Other Operating Expenses came in at -$4000.0 in Q1 2025, down 100.11% quarter-over-quarter from $3.7 million in Q4 2024.
Zentalis Pharmaceuticals (ZNTL) Other Operating Expenses (2023 - 2025) Analysis & Trends
Zentalis Pharmaceuticals' Other Operating Expenses history runs 3 years deep, the most recent figure standing at -$4000.0 for Q1 2025.
- On a quarterly basis, Other Operating Expenses changed N/A year-over-year to -$4000.0 in Q1 2025; TTM through Dec 2025 was -$4000.0, a 100.11% decrease from a year earlier, with the FY2024 full-year figure at $3.7 million, down 91.8% from the prior year.
- Other Operating Expenses declined to -$4000.0 in Q1 2025 per ZNTL's latest filing, from $3.7 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $45.6 million in Q2 2023 and bottomed at -$4000.0 in Q1 2025.
- The 3-year median for Other Operating Expenses is $3.7 million (2024), against an average of $16.4 million.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Zentalis Pharmaceuticals | 302.14 Mn | 302.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -4,000.00 |
| Dec 31, 2024 | 3.74 Mn |
| Jun 30, 2023 | 45.57 Mn |